Skip to content

Clinical trials

Phase 2 Lymphoma, Large-Cell, Anaplastic trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large-Cell, Anaplastic Phase: Phase 2 Country / region: France Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20061
20081
20092
20121
20151
20161
20181

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting1
Terminated1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC3
Seagen Inc.2
BeiGene1
Bristol-Myers Squibb1
Hoffmann-La Roche1
Institut Paoli-Calmettes1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large-Cell, Anaplastic10
Lymphoma, Non-Hodgkin5
Immunoblastic Lymphadenopathy4
Lymphoma4
Hodgkin Disease3
Lymphoma, Follicular3
Lymphoma, Large B-Cell, Diffuse3
Lymphoma, T-Cell, Cutaneous3
Breast Neoplasms2
Burkitt Lymphoma2

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.